Patient Care Specialty Areas
36%of exam
Infectious DiseasesCardiologyRenal & EndocrineCritical CareGI & ToxicologyOnc & Peds
Therapeutics & Patient Management
36%of exam
Professional Practice
28%of exam
Quick Facts
- Exam
- BCPS
- Credential
- Board Certified Pharmacotherapy Specialist
- Questions
- 150 (125 scored + 25 unscored)
- Time
- 3 hours 45 minutes
- Pass Score
- 500/800 scaled
- Format
- CBT at Pearson VUE
- Level
- Specialty certification
- Blueprint
- Sept 2024 (current)
Sepsis Hour-1 Bundle
Lactate | Cultures | Antibiotics | Fluids | Pressors
Lactate: measure levelCultures: before antibioticsAntibiotics: within one hourFluids: 30 mL/kg bolusPressors: if still hypotensive
Antidote Picker
- Acetaminophen overdose→N-acetylcysteine(Give early)
- Opioid overdose→Naloxone(IV, IM, or IN)
- Benzodiazepine overdose→Flumazenil(Seizure risk caution)
- Warfarin major bleed→Vitamin K plus PCC
- Heparin overdose→Protamine sulfate
- Iron overdose→Deferoxamine
- Methanol or ethylene glycol→Fomepizole
Infectious Diseases Pearls
- Vancomycin AUC
- 400-600 (mg*h/L) target
- Vancomycin trough
- 15-20 mg/L serious infection
- MRSA coverage
- Vancomycin, linezolid, daptomycin
- Daptomycin lung use
- Inactivated by pulmonary surfactant
- C. diff first-line
- Oral vancomycin or fidaxomicin
- Empiric sepsis timing
- Antibiotics within one hour
- Beta-lactam cross-reactivity
- Less than 1 percent
Warfarin INR Targets
Standard 2-3 | Mechanical valve 2.5-3.5
Standard indications: INR 2-3Mechanical mitral valve: 2.5-3.5Atrial fibrillation: INR 2-3VTE treatment: INR 2-3
Vasopressor & Shock Drug Picker
- Septic shock first-line→Norepinephrine
- Refractory septic shock→Add vasopressin
- Cardiogenic shock→Dobutamine
- Anaphylactic shock→IM epinephrine
- Unstable bradycardia→Atropine
- Post-arrest hypotension→Norepinephrine or dopamine
Cardiology Pearls
- Warfarin INR
- Target range 2-3
- Mechanical valve INR
- Target range 2.5-3.5
- HFrEF core therapy
- ARNI, beta-blocker, MRA, SGLT2i
- HF beta-blockers
- Carvedilol, succinate metoprolol, bisoprolol
- High-intensity statins
- Atorvastatin 40-80, rosuvastatin 20-40
- Stroke risk tool
- CHA2DS2-VASc score
- Bleeding risk tool
- HAS-BLED score
- Digoxin toxicity
- Level above 2 ng/mL
Renal, Pain & Endocrine
- CrCl equation
- Cockcroft-Gault formula
- GFR equation
- CKD-EPI formula
- Opioid reversal
- Naloxone
- A1c goal
- Below 7 percent typical
- Metformin renal caution
- Avoid if CrCl below 30
- Chronic pain first-line
- Non-opioid therapy preferred
Critical Care, Neuro & Pulm
- Sepsis lactate threshold
- Above 2 mmol/L
- First-line vasopressor
- Norepinephrine
- Status epilepticus first-line
- IV benzodiazepine
- COPD exacerbation therapy
- Bronchodilator plus corticosteroid
- Severe asthma therapy
- Systemic corticosteroids
- ARDS ventilation strategy
- Low tidal volume, 6 mL/kg
GI, Psych & Toxicology
- Acetaminophen antidote
- N-acetylcysteine
- Benzodiazepine antidote
- Flumazenil, use cautiously
- H. pylori regimen
- PPI plus two antibiotics
- Serotonin syndrome triad
- Autonomic, neuromuscular, mental changes
- Lithium therapeutic level
- 0.6-1.2 mEq/L
Onc, Peds & Immune
- Neutropenic fever threshold
- ANC below 500
- Highly emetogenic prophylaxis
- NK1, 5-HT3, steroid combo
- ACEi/ARB in pregnancy
- Teratogenic, avoid entirely
- Anaphylaxis first-line
- IM epinephrine
Strong CYP3A4 Inhibitors
Azoles, macrolides, protease inhibitors, grapefruit juice
Ketoconazole: azole antifungalClarithromycin: macrolide antibioticRitonavir: protease inhibitorGrapefruit juice: dietary source
ADE vs ADR
ADE
- Any harm from medication
- Includes preventable errors
- Broader definition overall
ADR
- Drug-specific adverse response
- Occurs at normal dose
- Excludes error causation
Errors included vs excluded
TDM Sampling Timing
- Vancomycin level→Trough before dose 4(or AUC-based)
- Aminoglycoside level→Peak and trough
- Phenytoin level→Trough, check albumin
- Lithium level→Trough, 12h post-dose
- Digoxin level→Trough, 6-8h post-dose
Treatment Planning & PK
- Volume of distribution
- Apparent distribution space
- High Vd drugs
- Lipophilic, tissue-bound agents
- First-order kinetics
- Constant fraction eliminated
- Zero-order kinetics
- Constant amount, saturable
- Steady state timing
- About 5 half-lives
- Loading dose formula
- Vd times target level
First-Order vs Zero-Order
First-Order
- Constant fraction eliminated
- Most drugs follow this
- Proportional to concentration
Zero-Order
- Constant amount eliminated
- Phenytoin and ethanol
- Enzyme pathway saturates
Proportional vs fixed rate
Therapeutic Implementation
- Fastest onset route
- IV push administration
- Oral bioavailability
- Usually below 100 percent
- Medication reconciliation timing
- Every care transition point
- High-alert medications
- Insulin, anticoagulants, opioids
- Tall man lettering
- Reduces look-alike errors
CrCl vs eGFR
CrCl (Cockcroft-Gault)
- Estimates creatinine clearance
- Uses actual weight
- Standard for drug dosing
eGFR (CKD-EPI)
- Estimates glomerular filtration
- No weight required
- Standard for CKD staging
Dosing vs staging use
Outcomes & Monitoring
- Beers Criteria
- Flags risky elderly meds
- STOPP/START tool
- Elderly prescribing screen
- ADE definition
- Any harm from medication
- ADR definition
- Drug-specific adverse response
- Strong CYP3A4 inhibitors
- Azoles, macrolides, ritonavir
- TDM drug list
- Vanc, aminoglycosides, phenytoin, lithium
- Adherence metric
- PDC or MPR ratio
Bioavailability vs Bioequivalence
Bioavailability
- Fraction reaching systemic circulation
- IV route equals 100%
- Depends on administration route
Bioequivalence
- Compares two drug products
- Generic versus brand comparison
- Same rate and extent
Absorption vs product comparison
Beers Criteria Focus
Avoid high-risk meds in older adults
Benzodiazepines: fall riskAnticholinergics: cognitive riskNSAIDs: renal and GI riskFirst-gen antihistamines: avoid use
Sensitivity vs Specificity
Sensitivity
- True positive rate
- Rules out disease
- High value means few false-negatives
Specificity
- True negative rate
- Rules in disease
- High value means few false-positives
SnNout vs SpPin
Quality of Care & Safety
- Common error type
- Wrong-dose errors frequent
- Sentinel event
- Serious reportable harm event
- Root cause analysis
- Systems-based error review
- Guideline sources
- AHA/ACC, ADA, IDSA
- Preventive care focus
- Immunizations and screenings
NNT vs NNH
NNT
- Number needed to treat
- Lower value is better
- Measures treatment benefit
NNH
- Number needed to harm
- Higher value is better
- Measures treatment risk
Benefit measure vs harm measure
Evidence-Based Practice
- Statistical significance
- P-value below 0.05
- NNT meaning
- Patients treated per benefit
- NNH meaning
- Patients treated per harm
- Top evidence level
- Systematic review, meta-analysis
- Bias control methods
- Randomization and blinding
- Confidence interval use
- Shows estimate precision
Efficacy vs Effectiveness
Efficacy
- Ideal controlled trial conditions
- Measured in RCT setting
- Best-case treatment result
Effectiveness
- Real-world practice conditions
- Measured in routine care
- Actual patient outcome
Trial result vs real-world result
Practice Management
- CPOE purpose
- Reduces prescribing errors
- Clinical decision support
- Point-of-care alerts
- Formulary oversight
- P&T committee decides
- Cost-effectiveness analysis
- Cost per health outcome
- MUE meaning
- Medication use evaluation
- Emergency preparedness role
- Maintain pharmacy service continuity
Common Traps
Scored vs Unscored Items
125 items scored ≠ 25 items unscored pretest
Recertification Cycles Differ
Pre-2024 cycle: exam only ≠ 2024+ cycle: exam plus 20 CPD
Practice Experience vs Residency
3 years practice needed ≠ PGY1 residency alternative path
Domain Weight Confusion
Areas 1 and 2 tie ≠ Both weighted 36 percent
CrCl vs eGFR Use
CrCl for drug dosing ≠ eGFR for CKD staging
Efficacy vs Effectiveness
Efficacy is trial result ≠ Effectiveness is real-world result
First-Time vs Overall Pass Rate
First-time rate higher typically ≠ Overall rate includes retakes
Last Minute
- 1.150 items: 125 scored, 25 unscored
- 2.Exam time: 3h45m total
- 3.Passing score: 500 of 800
- 4.Weights: 36/36/28 percent
- 5.Area 1: Patient Care Specialty
- 6.Area 2: Therapeutics and Management
- 7.Area 3: Professional Practice topics
- 8.Eligibility: license plus 3-year practice
- 9.Alt pathway: PGY1 residency accepted
- 10.Recertify every 7 years
- 11.Fee: $600 initial, $300 retake
Buy on AmazonSame family resources
Explore More BPS Pharmacy Specialty Certifications
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
More From This Family
Videos and articles for deeper review.
VideoFREE BCPS Exam Guide 2026: BPS Pharmacotherapy CertThis examVideoFREE NABP FPGEE Exam Guide + Pass Plan (2026)This examVideoFREE BCOP Exam Guide 2026: Oncology Pharmacist PrepArticleFREE BCPS Exam Guide 2026: BPS Pharmacotherapy Cert20 min readArticleFREE NABP FPGEE Exam Guide + Pass Plan (2026)22 min readArticleFREE BCOP Exam Guide 2026: Oncology Pharmacist Prep10 min readArticleBCACP Exam Guide 2026: Ambulatory Care Pharmacy Prep8 min read